Studies on the mechanism of telavancin decreased susceptibility in a laboratory-derived mutant

Microbial Drug Resistance

Volumn 19, Issue 4, 2013, Pages 247-255

  Song, Yang ^a   Lunde, Christopher S ^b   Benton, Bret M ^b,c   Wilkinson, Brian J ^a  

^a ILLINOIS STATE UNIVERSITY   (United States)

^b THERAVANCE INC   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CAROTENOID; CELL SURFACE PROTEIN; DAPTOMYCIN; HYDROLASE; IMMUNOGLOBULIN G; PHENOL; TELAVANCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLYSIS; BACTERIAL STRAIN; CELL MEMBRANE FLUIDITY; CELL WALL; DOWN REGULATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; LIPID COMPOSITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; STAPHYLOCOCCUS AUREUS; UPREGULATION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CELL MEMBRANE; CELL WALL; DAPTOMYCIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; MEMBRANE FLUIDITY; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; TRANSCRIPTOME; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84880879500     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2012.0195     Document Type: Article

References (50)

1. Bayer, A.S., R. Prasad, J. Chandra, A. Koul, M. Smriti, A. Varma, R.A. Skurray, N. Firth, M.H. Brown, S.P. Koo, and M.R. Yeaman. 2000. In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect. Immun. 68:3548-3553. (Pubitemid 30340456)
2. Chambers, H.F., and F.R. Deleo. 2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7:629-641.
3. Clarke, S.R. 2010. Phenol-soluble modulins of Staphlococcus aureus lure neutrophils into battle. Cell Host Microbe. 7: 423-424.
4. Delaune, A., O. Poupel, A. Mallet, Y.-M. Coic, T. Msadek, and S. Dubrac. 2011. Peptidoglycan crosslinking relaxation plays an important role in Staphylococcus aureus WalKRdependent cell viability. Plos One 6:e17054.
5. Draghi, D.C., B.M. Benton, K.M. Krause, C. Thornsberry, C. Pillar, and D.F. Sahm. 2008. Comparative surveillance study of telavancin activity against recently collected grampositive clinical isolates from across the United States. Antimicrob. Agents Chemother. 52:2383-2388. (Pubitemid 351915666)
6. Dubrac, S., I.G. Boneca, O. Poupel, and T. Msadek. 2007. New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J. Bacteriol. 189:8257-8269. (Pubitemid 350178938)
7. Gardete, S., C. Kim, B.M. Hartmann, M. Mwangi, C.M. Roux, P.M. Dunman, H.F. Chambers, and A. Tomasz. 2012. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin-resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. Plos Pathogens 8:e1002505.
8. Gustafson, J.E., B. Berger-Bächi, A. Strässle, and B.J. Wilkinson. 1992. Autolysis of methicillin-resistant and-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36:566-572.
9. Hanawa-Suetsugu, K., M. Takagi, H. Inokuchi, H. Himeno, and A. Muto. 2002. SmpB functions in various steps of trans-translation. Nucleic Acids Res. 30:1620-1629. (Pubitemid 34679737)
10. Hegde, S.S., N. Reyes, R. Skinner, and S. Difuntorum. 2008. Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus. J. Antimicrob. Chemother. 61:169-172.
11. Higgins, D.L., R. Chang, D.V. Debabov, J. Leung, T. Wu, K.M. Krause, E. Sandvik, J.M. Hubbard, K. Kaniga, D.E. Schmidt, Jr., Q. Gao, R.T. Cass, D.E. Karr, B.M. Benton, and P.P. Humphrey. 2005. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49:1127-1134. (Pubitemid 40327734)
12. Howden, B.P., J.K. Davies, P.D. Johnson, T.P. Stinear, and M.L. Grayson. 2010. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanism, laboratory detection, and clinical implications. Clin. Microbiol. Rev. 23:99-139.
13. Johnson, J.K., A.D. Harris, M.D. Shardell, J.C. McGregor, K.A. Thom, and E.N. Perencevich. 2011. Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients. Antimicrob. Agents Chemother. 55:1082-1087.
14. Kaenjak, A., J.E. Graham, and B.J. Wilkinson. 1993. Choline transport activity in Staphylococcus aureus induced by osmotic stress and low phosphate concentrations. J. Bacteriol. 175:2400-2406. (Pubitemid 23123516)
15. Klevens, R.M., M.A. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, L.H. Harrison, R. Lynfield, G. Dumyati, J.M. Townes, A.S. Craig, E.R. Zell, G.E. Fosheim, L.K. McDougal, R.B. Carey, and S.K. Fridkin. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771. (Pubitemid 47598444)
16. Koehl, J.L., A. Muthaiyan, R.K. Jayaswal, K. Ehlert, H. Labischinski, and B.J. Wilkinson. 2004. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 48:3749-3757. (Pubitemid 39304599)
17. Kosowska-Shick, K., C. Clark, G.A. Pankuch, P. McGhee, B. Dewasse, L. Beachel, and P.C. Appelbaum. 2009. Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies. Antimicrob. Agents Chemother. 53:4217-4224.
18. Lamichhane-Khadka, R., J.T. Riordan, A. Delgado, A. Muthaiyan, T.D. Reynolds, B.J. Wilkinson, and J.E. Gustafson. 2008. Genetic changes that correlate with the pine-oil disinfectant-reduced susceptibility mechanism of Staphylococcus aureus. J. Appl. Microbiol. 105:1973-1981.
19. Leadbetter, M.R., S.M. Adams, B. Bazzini, P.R. Fatheree, D.E. Karr, K.M. Krause, B.M. Lam, M.S. Linsell, M.B. Nodwell, J.L. Pace, K. Quast, J.P. Shaw, E. Soriano, S.G. Trapp, J.D. Villena, T.X. Wu, B.G. Christensen, and J.K. Judice. 2004. Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424). J. Antibiot. (Tokyo) 57:326-336. (Pubitemid 38811717)
20. Ledala, N., B. J. Wilkinson, and R. K. Jayaswal. 2006. Effect of oxacillin and tetracycline on autolysis, autolysis processing and atl transcription in Staphylococcus aureus. Int. J. Antimicrob. Agents 27:518-524. (Pubitemid 43767078)
21. Li, M., D.J. Cha, Y. Lai, A.E. Villaruz, D.E. Sturdevant, and M. Otto. 2007. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol. Microbiol. 66: 1136-1147. (Pubitemid 350115022)
22. Liu, G.Y., A. Essex, J.T. Buchanan, V. Datta, H.M. Hoffman, J.F. Bastian, J. Fierer, and V. Nizet. 2005. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 202:209-215. (Pubitemid 41043816)
23. Lunde, C.S., S.R. Hartouni, J.W. Janc, M. Mammen, P.P. Humphrey, and B.M. Benton. 2009. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. Antimicrob. Agents Chemother. 53:3375-3383.
24. Mishra, N.N., G.Y. Liu, M.R. Yeaman, C.C. Nast, R.A. Proctor, J. McKinnell, and A.S. Bayer. 2011. Carotenoidrelated alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob. Agents Chemother. 55:526-531.
25. Mishra, N.N., J. McKinnell, M.R. Yeaman, A. Rubio, C.C. Nast, L. Chen, B.N. Kreiswirth, and A.S. Bayer. 2011. In vitro cross-resistance of daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates. Antimicrob. Agents Chemother. 55:4012-4018.
26. Muthaiyan, A., J.A. Silverman, R.K. Jayaswal, and B.J. Wilkinson. 2008. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob. Agents Chemother. 52:980-990. (Pubitemid 351358377)
27. Nielsen, L.E., D.R. Kadavy, S. Rajagopal, R. Drijber, and K.W. Nickerson. 2005. Survey of extreme solvent tolerance in gram-positive cocci: membrane fatty acid changes in Staphylococcus haemolyticus grown in toluene. Appl. Environ. Microbiol. 71:5171-5176. (Pubitemid 41338245)
28. Novick, R.P., and E. Geisinger. 2008. Quorum sensing in staphylococci. Annu. Rev. Genet. 42:541-564.
29. Pfeltz, R.F., and B.J. Wilkinson. 2004. The escalating challenge of vancomycin resistance in Staphylococcus aureus. Curr. Drug Targets Infect Disord. 4:273-294. (Pubitemid 39534762)
30. Qoronfleh, M.W., and B.J. Wilkinson. 1986. Effects of growth of methicillin-resistant and-susceptible Staphylococcus aureus in the presence of b-lactams on peptidoglycan structure and susceptibility to lytic enzymes. Antimicrob. Agents Chemother. 29:250-257. (Pubitemid 16162934)
31. Record, M.T. Jr., E.S. Courtenay, D.S. Cayley, and H.J. Guttman. 1998. Responses of E. coli to osmotic stress: large changes in amounts of cytoplasmic solutes and water. Trends Biochem. Sci. 23:143-148. (Pubitemid 28189526)
32. Reyes, D., D.O. Andrey, A. Monod, W.L. Kelley, G. Zhang and A.L. Cheung. 2011. Coordinated regulation by AgrA, SarA and SarB and SarR to control agr expression in Staphyloccus aureus. J. Bacteriol. 193:6020-6031.
33. Säd-Salim, B., P.M. Dunman, F.M. McAleese, D. Macapagal, E. Murphy, P.J. McNamara, S. Arvidson, T.J. Foster, S.J. Projan, and B.N. Kreiswirth. 2003. Global regulation of Staphylococcus aureus genes by rot. J. Bacteriol. 185:2610-2619.
34. Schweizer, M.L., J.P. Furuno, G. Sakoulas, J.K. Johnson, A.D. Harris, M.D. Shardell, J.C. McGregor, K.A. Thom, and E.N. Perencevich. 2011. Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients. Antimicrob Agents Chemother. 55:1082-1087
35. Shaw, L.N., E. Golonka, G. Szmyd, S.J. Foster, J. Travis, and J. Potempa. 2005. Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype. J. Bacteriol. 187:1751-1762. (Pubitemid 40289377)
36. Shimizu. Y, and T. Ueda. 2002. The role of SmpB protein in trans-translation. FEBS Lett. 514:74-77. (Pubitemid 34251246)
37. Shoji, M., L. Cui, R. Iizuka, A. Komoto, H.M. Neoh, Y. Watanabe, T. Hishinuma, and K. Hiramatsu. 2011. The walK and clpP mutations confer reduced vancomycin susceptibility on Staphylococcus aureus. Antimicrob. Agents Chemother. 55:3870-3081.
38. Singh, V.K., D.S. Hattangady, E.S. Giotis, A.K. Singh, N.R. Chamberlain, M.K. Stuart, and B.J. Wilkinson. 2008. Insertional inactivation of branched chain a-keto acid dehydrogenase in Staphylococcus aureus leads to decreased branched-chain membrane fatty acid content and increased susceptibility to certain stresses. Appl. Environ. Microbiol. 74:5882-5890.
39. Song, Y., C.S. Lunde, B.M. Benton, and B.J. Wilkinson. 2012. Further insights into the mode of action of the lipoglycopeptide telavancin through global gene expression studies. Antimicrob. Agents Chemother. 56:3157-3164.
40. Stapleton, M.R., M.J. Horsburgh, E.J. Hayhurst, L. Wright, I.-M. Jonsson, A. Tarkowski, J.F. Kokai-Kun, J.J. Mond, and S.J. Foster. 2007. Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus. J. Bacteriol. 189:7316-7325. (Pubitemid 47557346)
41. Tannake, Y., K. Morikawa, Y. Ohki, M. Yao, K. Tsumot, N. Watanabe, T. Ohta, and I. Tanaka. 2007. Structural and mutational analyses of Drp35 from Staphylococcus aureus. J. Biol. Chem. 282:5770-5780.
42. Townsend, D.E., A. Kaenjak, R.K. Jayaswal, and B.J. Wilkinson. 2006. Proline is biosynthesized from arginine in Staphylococcus aureus. Microbiology. 142:1491-1497.
43. Tsuji, B.T., M.J. Rybak, K.L. Lau, and G. Sakoulas. 2007. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51:1089-1091. (Pubitemid 46355301)
44. Utaida, S., P.M. Dunman, D. Macapagal, E. Murphy, S.J. Projan, V.K. Singh, R.K. Jayaswal, and B.J. Wilkinson. 2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149:2719-2732. (Pubitemid 37279247)
45. Vijaranakul, U., M.J. Nadakavukaren, B.L. de Jonge, B.J. Wilkinson, and R.K. Jayaswal. 1995. Increased cell size and shortened peptidoglycan interpeptide bridge of NaCl-stressed Staphylococcus aureus and their reversal by glycine betaine. J. Bacteriol. 177:5116-5121.
46. Wilkinson, B.J., A.Muthaiyan, and R.K. Jayaswal. 2005. The cell wall stress stimulon of Staphylococcus aureus and other gram-positive bacteria. Curr. Med. Chem. Anti-Infective Agents. 4:259-276. (Pubitemid 40974827)
47. Xue, T., Y. You, D. Hong, H. Sun, and B. Sun. 2011. The Staphylococcus aureus KdpDE two-component system couples extracellular K+ sensing and Agr signaling to infection programming. Infect Immun. 79:2154-2167.
48. Yang, S.J., Y.Q. Xiong, S. Boyle-Vavra, R. Daum, T. Jones, and A.S. Bayer. 2010. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin- resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect"). Antimicrob. Agents Chemother. 54:3161-3169.
49. Zhang, Y.M., and C.O. Rock. 2008. Membrane lipid homeostasis in bacteria. Nat. Rev. Microbiol. 6:222-233. (Pubitemid 351256317)
50. Zhu, K., D.O. Bayles, A. Xiong, R.K. Jayaswal, and B.J. Wilkinson. 2005. Precursor and temperature modulation of fatty acid composition and growth of Listeria monocytogenes cold-sensitive mutants with transposon-interrupted branched-chain a-keto acid dehydrogenase. Microbiology 151:615-623. (Pubitemid 40277764)